M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
Improving Outcomes From Transcatheter Aortic Valve Implantation: Protecting the Brain From the Heart
Steven R. Messé,Michael J. Mack +1 more
TL;DR: The high rate of clinical stroke in this study, relative to prior studies of TAVI, is likely related to the use of early and rigorous neurological assessments, and the device was still associated with reduced infarct burden when accounting for all brain territories.
Journal ArticleDOI
Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER‐2
Bibhu D. Mohanty,Megan Coylewright,Ashton Sequeira,Doosup Shin,Yangbo Liu,Ditian Li,Michael G. Fradley,Maria Alu,Michael J. Mack,Samir R. Kapadia,Susheel Kodali,Vinod H. Thourani,Raj Makkar,Martin B. Leon,David J. Malenka +14 more
TL;DR: The purpose of this study is to investigate the viability of transcatheter aortic valve replacement (TAVR) for severe symptomatic aorta stenosis in patients with prior chest radiation therapy (cXRT).
Journal ArticleDOI
Use of left atrial appendage occlusion among older cardiac surgery patients with preoperative atrial fibrillation: a national cohort study
Daniel J. Friedman,Jeffrey G. Gaca,Tongrong Wang,S. Chris Malaisrie,David R. Holmes,Jonathan P. Piccini,Rakesh M. Suri,Michael J. Mack,Vinay Badhwar,Jeffrey P. Jacobs,Eric D. Peterson,Shein-Chung Chow,J. Matthew Brennan +12 more
TL;DR: Substantial variability in use of S-LAAO exists, and the procedure is being deferred in the patients that may be poised to benefit the most (i.e., those with increased CHA 2 DS 2 -VASc score-defined stroke risk).
Journal ArticleDOI
Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial.
Zachary L. Cox,Sandip Zalawadiya,Matheus Simonato,Björn Redfors,Lak N. Kotinkaduwa,Michael R. Zile,James E. Udelson,D. Scott Lim,Paul A. Grayburn,Michael J. Mack,William T. Abraham,Gregg W. Stone,JoAnn Lindenfeld +12 more
TL;DR: In the COAPT trial, a central committee of heart failure (HF) specialists optimized guideline-directed medical therapies (GDMT) and documented medication and goal dose intolerances before patient enrollment as discussed by the authors .
Journal ArticleDOI
TCT-802 Effects of Pulmonary Hypertension on Transcatheter Mitral Valve Repair Outcomes: Analysis of The STS/ACC TVT Registry
Rasha Al-Bawardy,Sreekanth Vemulapalli,Vinod H. Thourani,Michael J. Mack,Eyal Ben Assa,Igor F. Palacios,Ignacio Inglessis,Jacob P. Dal-Bianco,Jonathan J. Passeri,Serguei Melnitchouk,Gus J. Vlahakes,Arminder S. Jassar,David Dai,Sammy Elmariah +13 more
TL;DR: The impact of pHTN on 1-year all-cause mortality after mitral valve surgery for mitral regurgitation and its prognostic impact on patients undergoing transcatheter mitral valves repair with MitraClip is assessed.